Reata Pharmaceuticals, Inc.
METHODS OF TREATING ALPORT SYNDROME USING BARDOXOLONE METHYL OR ANALOGS THEREOF

Last updated:

Abstract:

The present invention provides methods of treating or preventing Alport syndrome in a patients in need thereof using bardoxolone methyl or analogs thereof, and/or improving the kidney function of patients who have been diagnosed with Alport syndrome.

Status:
Application
Type:

Utility

Filling date:

11 Feb 2021

Issue date:

3 Jun 2021